Home » Stocks » Zydus Lifesciences Ltd

Zydus Lifesciences Ltd

The live share price of Zydus Lifesciences Ltd (ZYDUSLIFE) as on 30 May 10:21am is ₹505.75 from NSE/BSE.

ZYDUSLIFE NSE

₹505.75 ▼-1.23% (-6.3)

As on May 30, 2023 03:51 PM IST

How do you feel today about Zydus Lifesciences Ltd?

Key Metrics

PE Ratio

27.78

PB Ratio

2.72

Dividend Yield

1.19%

Sector PB

4.49

Sector PE

33.72

Sector Div Yld

0.82%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

sec-img

Sector

Health Care

sec-img

Industry

Pharmaceuticals

sec-img

Market Cap

Midcap, ₹51,829 Cr

Zydus Lifesciences Ltd is an India-based life sciences company. The Company has a pipeline for Biologics and Vaccines.

The following charts display the financial performance of the Zydus Lifesciences Ltd (ZYDUSLIFE) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Zydus Lifesciences Ltd (ZYDUSLIFE), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

sec-img

Sector

Health Care

sec-img

Industry

Pharmaceuticals

sec-img

Market Cap

Midcap, ₹51,829 Cr

Financials

Income Statement

(INR) Y/Y Change
Revenue 17,424 Cr -2.38%
Operating Expense 13,986 Cr +1222.83%
Net Income 1,865 Cr -58.42%
Net Profit Margin 10.71% -57.4%
Earning Per Share 19 -55.97%
EBITDA 3,437 Cr -41.97%

Balance sheet

(INR) Y/Y Change
Cash & short-term Inv 3,460 Cr +218.26%
Total Assets 27,641 Cr +16.31%
Total Liabilities 8,587 Cr -2.8%
Total Equity 19,053 Cr +27.62%
Shares Outstanding 102.37 Cr -
Price to Book 1.9 -37.28%
Return on Assets 17.46% +93.36%
Return on Capital 27.35 Cr +63.97%

Cash Flows

(INR) Y/Y Change
Net Income 1,865 Cr -58.42%
Cash from Operations 2,104 Cr -36.12%
Cash from Investing 1,137 Cr -235.9%
Cash from Financing -868 Cr -65.92%
Net Change in Cash 2,372 Cr -2721.99%
Free Cash Flow 901 Cr -63.05%
Total Promoter Holding
74.98%
Unpledged
Foreign Institutions
3.42%
Foreign Institutions
Retail & Others
8%
Retail & Others
Other Parties
Other Domestic Institutions
8%
Insurance Firms
Others
Mutual Funds
5.59%
Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

27.27

1Y Return

▲8.03%

CIPLA

Cipla Ltd

PE Ratio

27.52

1Y Return

▼-2.73%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

16.8

1Y Return

▲3.4%

TORNTPHARM

Torrent Pharmaceuticals Ltd

PE Ratio

69.48

1Y Return

▲18.78%

Latest News

latest-news

Stocks to watch today — May 11, 2023

3 weeks ago on The Hindu Businessline

Change since news ▼-2.23%

Buzzing stocks: L&T, Oil India, Asian Paints, HDFC Bank, HDFC AMC, Godrej Consumer, McLeod Russel, Lehar Footwears, Cadila Healthcare, RVNL, Siemens, Sanofi India, Dr Lal Path Labs, AB Capital, CARE Rating, PTC India Fin, Eicher, Gillette, Religare


FAQs on Zydus Lifesciences Ltd

How to buy Zydus Lifesciences Ltd stocks?

You can easily buy the stocks/shares of Zydus Lifesciences Ltd (ZYDUSLIFE) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Zydus Lifesciences Ltd?

The stock price of Zydus Lifesciences Ltd as on 30 May 2023 is ₹505.75

What is the 52-week High and Low of Zydus Lifesciences Ltd?

The 52-week high and low of Zydus Lifesciences Ltd (ZYDUSLIFE) is ₹530.85 and ₹329.8.

What is the PE and PB ratio of Zydus Lifesciences Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Zydus Lifesciences Ltd are 27.78 and 2.72 respectively.

What are the peers or stocks similar to Zydus Lifesciences Ltd?

The peers or stocks similar to Zydus Lifesciences Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Torrent Pharmaceuticals Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Zydus Lifesciences Ltd belong to?

Zydus Lifesciences Ltd (ZYDUSLIFE) belongs to the Pharmaceuticals sector.

What is the Market Cap of Zydus Lifesciences Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zydus Lifesciences Ltd (ZYDUSLIFE) is ₹51,829 Cr as of 30 May 2023

Can't decide whether or not to buy Zydus Lifesciences Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.